Brain diseases are increasingly common – How can their progression be slowed down?
Professor Mikko Airavaara is looking for new drugs to treat cerebral infarctions and neurodegenerative diseases.
Working for FinPharma: Professor Mikko Airavaara
The expertise of Mikko Airavaara, who graduated with a doctoral degree from the University of Helsinki’s Faculty of Pharmacy in 2006, is centred...
Mikko Airavaara started as a reviewing editor for eNeuro
Dr. Mikko Airavaara from Neuroscience Center, HiLIFE, University of Helsinki, is a new reviewing editor for eNeuro, an open-access journal...
Mikko Airavaara's interview in Scientific American
Article about finding new therapies for stroke and recent advances in targeting inflammation pathways.
Post-stroke delivery of neurotrophic factor MANF promotes functional recovery in rats
The neurotrophic factor MANF is neuroprotective when administered before experimental stroke. MANF also promoted reversal of stroke-induced...